All Stories

  1. Prediction of survival after fetoscopic laser surgery for early‐onset twin‐to‐twin transfusion syndrome
  2. Long COVID following SARS ‐ CoV ‐2 infection during pregnancy: An observational study in a large It...
  3. Sodium-Glucose Cotransporter 2 Inhibitors After Preeclampsia
  4. Single versus longitudinal scans in the third trimester: a multicenter randomized clinical trial on screening for late-onset intrauterine fetal growth restriction (The RCT on Evaluation of LAte Iugr Screening study)
  5. Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on “Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic ...
  6. Perinatal outcome after single intrauterine death in monochorionic twin pregnancy: systematic review and meta‐analysis
  7. Vaginal delivery of the second twin: simulation to improve trainee knowledge and comfort
  8. Standardising Simulation‐Based Obstetric Emergency Training: A Delphi Consensus Study
  9. Immunological profile of pregnant women with preconception immunity with or without vertical transmission of human cytomegalovirus to the fetus: a retrospective observational study
  10. Is parvovirus B19 infection upsurge in 2023–2024 associated with adverse pregnancy outcome?
  11. Antenatal Corticosteroids in Early and Late Fetal Growth Restriction
  12. Corpus Callosum to Choroid Plexus Distance for the Prenatal Diagnosis of Partial Agenesis or Hypoplasia of the Corpus Callosum
  13. Outcome in isolated partial agenesis of the corpus callosum: fetal medicine specialists need more data
  14. Reduction of planned cesarean delivery in twin pregnancy after a training intervention.
  15. Risk factors, prenatal diagnosis, and outcome of posterior placenta accreta spectrum disorders in patients with placenta previa or low‐lying placenta: A multicenter study
  16. What is the role of intrauterine transfusion after single intrauterine death in monochorionic twin pregnancies? Evidence from a systematic review and meta-analysis
  17. First‐trimester ultrasound markers for prediction of adverse outcome in monochorionic diamniotic twin pregnancy
  18. Outbreak of parvovirus‐B19 infection in pregnant women: Is it time to rethink a preconception or first trimester screening?
  19. Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus
  20. Spontaneous conception and pregnancy outcomes after multi‐agent chemotherapy and high‐dose radiotherapy for pelvic Ewing sarcoma: Case report and literature review
  21. Risk of Congenital Toxoplasmosis in Newborns from Mothers with Documented Infection: Experience from Two Referral Centres
  22. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women
  23. Serendipitous diagnosis of severe fetomaternal hemorrhage through maternal AB0 discrepancy
  24. Shoulder dystocia simulation program: evaluation of learning from practical obstetric multi-professional training and its impact on patient outcomes
  25. Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus
  26. Digital vs formal teaching of vaginal breech delivery: Which is the residents’ choice?
  27. Routine ultrasound does not improve instrument placement at operative vaginal delivery: An updated systematic review and meta‐analysis
  28. Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study
  29. The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO)
  30. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis
  31. Development and validation of a prognostic model to predict birth weight: individual participant data meta-analysis
  32. MV‐flow in the assessment of fetal vein of Galen aneurysmal malformation
  33. European association of perinatal medicine (EAPM) position statement: Screening, diagnosis and management of congenital anomalies of the umbilical cord
  34. Exploring the mystical relationship between the Moon, Sun, and birth rate
  35. Prenatal diagnosis of multiple gastric duplication cysts
  36. First-trimester cesarean scar pregnancy: a comparative analysis of treatment options from the international registry
  37. Intrapartum pyrexia, cardiotocography traces and histologic chorioamnionitis: a case-control study
  38. Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine
  39. Determinants of emergency Cesarean delivery in pregnancies complicated by placenta previa with or without placenta accreta spectrum disorder: analysis of ADoPAD cohort
  40. Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial
  41. ISUOG Practice Guidelines: performance of third‐trimester obstetric ultrasound scan
  42. Perinatal care in SARS-CoV-2 infected women: the lesson learnt from a national prospective cohort study during the pandemic in Italy
  43. Inherited episodic ataxia type 2 in pregnancy: A case report
  44. Indications for fetal echocardiography: Italian Society of Ultrasound in Obstetrics and Gynecology (SIEOG) guidelines using GRADE methodology
  45. Management of preterm labor: Clinical practice guideline and recommendation by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
  46. Comparison of practice vs theory model training for vacuum-assisted delivery: A randomized controlled trial
  47. Do differences in diagnostic criteria for late fetal growth restriction matter?
  48. Treatment of Early Cesarean Scar Pregnancy with Double Balloon Catheter: A Systematic Review of the Literature
  49. EP16.20: Consensus protocol for diagnosis and management of singleton pregnancies with vasa previa: interim findings from a Delphi study
  50. Perinatal outcome of monochorionic triamniotic triplet pregnancy: multicenter cohort study
  51. Small‐for‐gestational‐age fetus diagnosed in the second trimester: Possible etiologies and short‐term neonatal outcomes
  52. Hepatocellular carcinoma in pregnancy: A systematic review
  53. ISUOG Practice Guidelines (updated): fetal cardiac screening
  54. Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey
  55. Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system
  56. Obliterated cavum septi pellucidi: Clinical significance and role of fetal magnetic resonance
  57. Identification of bi‐allelic LFNG variants in three patients and further clinical and molecular refinement of spondylocostal dysostosis 3
  58. Editorial: Hypertensive disorders of pregnancy and the cardiovascular system: Causes, consequences, prevention and treatment
  59. Anthropometric Features and Third-Fourth Degree Perineal Tears
  60. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis
  61. Corrigendum to “The Italian guidelines on ultrasound in obstetrics and gynecology: Executive summary of recommendations for practice” [Eur. J. Obstetrics Gynecol. 279 (2022) 176–182]
  62. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum
  63. Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study
  64. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study
  65. Reduced fetal growth velocity and weight loss are associated with adverse perinatal outcome in fetuses at risk of growth restriction
  66. Prognostic Value of Amniotic Fluid Viral Load to Predict Adverse Outcome in Pregnancies Complicated by Congenital Cytomegalovirus Infection: A Multicenter Study
  67. Application of IOTA stepwise diagnostic flowchart to fetal anomalies: INDIAMAN‐20 (INstant DIAgnoses of Major ANomalies) protocol
  68. Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies
  69. Antenatal corticosteroids and perinatal outcome in late fetal growth restriction: analysis of prospective cohort
  70. Sex-dependent association between variability in infants’ OXTR methylation at birth and negative affectivity at 3 months
  71. Referral scan for congenital anomalies: time to agree on indications
  72. Current practice in the diagnosis and management of fetal growth restriction: An international survey
  73. Post-partum Women’s Anxiety and Parenting Stress: Home-Visiting Protective Effect During the COVID-19 Pandemic
  74. Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters
  75. Maternal Right Ventricular and Left Atrial Function in Uncomplicated Twin Pregnancies: A Longitudinal Study
  76. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
  77. Maternal Left Ventricular Function in Uncomplicated Twin Pregnancies: A Speckle-Tracking Imaging Longitudinal Study
  78. Third‐trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study
  79. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study
  80. Risk factors for anxiety and depression among pregnant women during COVID ‐19 pandemic—Results of a web‐based multinational cross‐sectional study
  81. Prenatal predictors of adverse perinatal outcome in congenital cytomegalovirus infection: a retrospective multicenter study
  82. Is Brain-Derived Neurotropic Factor Methylation Involved in the Association Between Prenatal Stress and Maternal Postnatal Anxiety During the COVID-19 Pandemic?
  83. An update of diagnostic efficacy of ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  84. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study
  85. Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)
  86. Ultrasound and MRI appearance of abnormally adherent placenta in a woman with Asherman's syndrome
  87. Incidence, clinical features and perinatal outcome in anomalous fetuses with late‐onset growth restriction: cohort study
  88. ISUOG Practice Guidelines (updated): performance of the routine mid‐trimester fetal ultrasound scan
  89. Timing of intra‐fetal laser therapy for twin reversed arterial perfusion ( TRAP ) sequence: Retrospective series and systematic review and meta‐analysis
  90. Chorionicity, birth weight discordance and neonatal morbidity in uncomplicated twin pregnancies delivered from 36 weeks
  91. Not yet the last word on fundal pressure
  92. Perinatal and 2-year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 randomised trial protocol
  93. Exclusive breastfeeding and maternal postnatal anxiety contributed to infants' temperament issues at 6 months of age
  94. Inappropriate left ventricular mass after HELLP syndrome inappropriate LVM after HELLP syndrome
  95. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
  96. Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach
  97. Organization of an obstetrics unit during the COVID-19 pandemic: a short literature review
  98. HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia
  99. Obstetric consequences of a false‐positive diagnosis of large‐for‐gestational‐age fetus
  100. Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
  101. Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy
  102. In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19
  103. Role of prenatal magnetic resonance imaging in fetuses with isolated severe ventriculomegaly at neurosonography: A multicenter study
  104. Mode of birth in women with low-lying placenta: protocol for a prospective multicentre 1:3 matched case–control study in Italy (the MODEL-PLACENTA study)
  105. Longitudinal Doppler Assessments in Late Preterm Fetal Growth Restriction
  106. Fetal cerebral blood‐flow redistribution: analysis of Doppler reference charts and association of different thresholds with adverse perinatal outcome
  107. Fetoscopic laser ablation therapy in monochorionic diamniotic twin pregnancies with twin-to-twin transfusion syndrome treated at a single centre over 10 years: a retrospective study
  108. Depression and Anxiety in Mothers Who Were Pregnant During the COVID-19 Outbreak in Northern Italy: The Role of Pandemic-Related Emotional Stress and Perceived Social Support
  109. Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study
  110. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
  111. The hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  112. External validation of prognostic models to predict stillbirth using the International Prediction of Pregnancy Complications ( IPPIC ) Network database: an individual participant data meta‐analysis
  113. Hidden pandemic: COVID-19-related stress, SLC6A4 methylation, and infants’ temperament at 3 months
  114. ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics
  115. Prenatal maternal stress during the COVID-19 pandemic and infant regulatory capacity at 3 months: A longitudinal study
  116. Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study
  117. Maternal myocardial dysfunction after hemolysis, elevated liver enzymes, and low platelets syndrome: a speckle-tracking study
  118. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
  119. Pre-eclampsia and late fetal growth restriction
  120. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection
  121. Childbirth Care among SARS-CoV-2 Positive Women in Italy
  122. Maternal and neonatal outcomes of pregnancies complicated by late fetal growth restriction undergoing induction of labor with dinoprostone compared with cervical balloon: A retrospective, international study
  123. Pregnancy and COVID‐19: Do not overlook malaria
  124. Maternal hemodynamics, arterial stiffness and elastic aortic properties in twin pregnancy
  125. Measuring the Outcomes of Maternal COVID-19-related Prenatal Exposure (MOM-COPE): study protocol for a multicentric longitudinal project
  126. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
  127. Assessing risk factors for severe forms of COVID‐19 in a pregnant population: A clinical series from Lombardy, Italy
  128. External validation of prognostic models predicting pre-eclampsia: individual participant data meta-analysis
  129. The Impact of Preeclampsia on Women’s Health: Cardiovascular Long-term Implications
  130. Prenatal diagnosis of fetal anomalies from the third to the first trimester and back
  131. Retest positive for SARS‐CoV‐2 RNA of recovered pregnant women with COVID‐19
  132. Pregnancy prolongation for pre‐eclampsia: the obvious and the avoidable
  133. The MOM-COPE research project: Measuring the outcomes of maternal COVID19-related prenatal exposure
  134. Possible Coronavirus Disease 2019 Pandemic and Pregnancy
  135. SARS-CoV-2 infection testing at delivery: a clinical and epidemiological priority
  136. Standardising definitions for the pre-eclampsia core outcome set: A consensus development study
  137. Folic Acid Supplementation in Pregnancy
  138. Outcomes in Pregnancies With a Confined Placental Mosaicism and Implications for Prenatal Screening Using Cell-Free DNA
  139. Fetal cerebral Doppler changes and outcome in late preterm fetal growth restriction: prospective cohort study
  140. Maternal myocardial dysfunction after normotensive fetal growth restriction compared with hypertensive pregnancies: a speckle-tracking study
  141. Current use and performance of the different fetal growth charts in the Italian population
  142. ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID‐19
  143. ISUOG Interim Guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium: information for healthcare professionals – an update
  144. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: a retrospective analysis
  145. COVID ‐19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome
  146. A core outcome set for pre‐eclampsia research: An international consensus development study
  147. ISUOG Practice Guidelines: role of ultrasound in congenital infection
  148. Twin Reversed Arterial Perfusion Sequence: Current Treatment Options
  149. Identification of large-for-gestational age fetuses using antenatal customized fetal growth charts: Can we improve the prediction of abnormal labor course?
  150. Reply
  151. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre‐eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study
  152. Core outcome set for studies investigating management of selective fetal growth restriction in twins
  153. A case of combined aortic bioprosthetic valve degeneration and patient–prosthesis mismatch during pregnancy
  154. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
  155. Expectant Management of Hypertensive Disorders of Pregnancy and Future Cardiovascular Morbidity
  156. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  157. Genome‐wide cfDNA testing of maternal blood
  158. Antepartum and intrapartum risk factors for neonatal hypoxic–ischemic encephalopathy
  159. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  160. Perinatal outcomes of fetal intra-abdominal umbilical vein varix: a multicenter cohort study
  161. Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses
  162. Outcome of twin‐to‐twin transfusion syndrome in monochorionic monoamniotic twin pregnancies: a systematic review and meta‐analysis
  163. Prenatal ultrasound diagnosis of cavitation of ganglionic eminence
  164. Higher rate of early-onset preeclampsia in pregnancies following oocyte donation according to increasing maternal age
  165. Intracervical lakes as a sonographic marker of placenta accreta spectrum (PAS) in patients with previa and low‐lying placenta
  166. Effects of Antenatal Betamethasone on Fetal Doppler Indices and Short Term Fetal Heart Rate Variation in Early Growth Restricted Fetuses
  167. Agreement between anatomical M‐mode and tissue Doppler imaging in the assessment of fetal atrioventricular annular plane displacement in uncomplicated pregnancies: A prospective longitudinal study
  168. Ultrasound evaluation of left ventricular and aortic fibrosis after HELLP syndrome
  169. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
  170. Prenatal findings in oral‐facial‐digital syndrome type VI: Report of three cases and literature review
  171. Fetal anemia: Diagnosis and management
  172. Interobserver variability in MRI assessment of the severity of placenta accreta spectrum disorders
  173. Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert
  174. The contingent use of cell-free fetal DNA for prenatal screening of trisomies 21, 18, 13 in pregnant women within a national health service: A budget impact analysis
  175. Early Intraperitoneal Transfusion for Fetal Hydrops Caused by Parvovirus B19 Infection
  176. Evaluation of the quality and reliability of middle cerebral artery and umbilical artery Doppler images within an international randomized controlled trial
  177. Maternal blood flow to the placenta
  178. Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery
  179. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  180. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  181. Birthweight discordance and neonatal morbidity in twin pregnancies: A systematic review and meta‐analysis
  182. Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study
  183. Perinatal mortality, timing of delivery and prenatal management of monoamniotic twin pregnancy: systematic review and meta‐analysis
  184. Elastic properties of ascending aorta and ventricular–arterial coupling in women with previous pregnancy complicated by HELLP syndrome
  185. The use of ultrasound-indicated cerclage or cervical pessary in asymptomatic twin pregnancies with a short cervix at midgestation
  186. TRAP Sequence in Monochorionic/Monoamniotic (MC/MA) Discordant Twins: Two Cases Treated with Fetoscopic Laser Surgery
  187. Inpatient vs outpatient management and timing of delivery of uncomplicated monochorionic monoamniotic twin pregnancy: the MONOMONO study
  188. Ultrasonography Diagnosis
  189. Inappropriate left ventricular mass after preeclampsia: another piece of the puzzle Inappropriate LVM and PE
  190. Randomised Italian Sonography for occiput POSition Trial Ante vacuum (R.I.S.POS.T.A.)
  191. Maternal functional hemodynamics in uncomplicated twin pregnancies: a longitudinal study using impedance cardiography
  192. Ultrasound evaluation of left ventricular and aortic fibrosis after pre-eclampsia
  193. Risk of congenital toxoplasmosis in women with low or indeterminate anti-Toxoplasma IgG avidity index in the first trimester of pregnancy: an observational retrospective study
  194. PMD38 - CELL-FREE FETAL DNA AS A CONTINGENT PRENATAL SCREENING OF TRISOMIES CONDITIONAL TO A RISK ≥ 1:1,000 FOR ITALIAN PREGNANT WOMEN: AN ECONOMIC EVALUATION
  195. Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome
  196. Pre-eclampsia and heart failure: a close relationship
  197. The Effect of Chorionicity on Maternal Cardiac Adaptation to Uncomplicated Twin Pregnancy: A Prospective Longitudinal Study
  198. Prophylaxis for Fetal Growth Restriction: Aspirin and Low-Molecular-Weight Heparins
  199. Planned Home Versus Planned Hospital Births in Women at Low-Risk Pregnancy: A Systematic Review With Meta-analysis
  200. Twin-to-twin-transfusion syndrome: from amniodrainage to laser
  201. Etiology and Prognosis of Severe Ventriculomegaly Diagnosed at Late Gestation
  202. Weight discordance and perinatal mortality in twin pregnancy: systematic review and meta‐analysis
  203. Longitudinal reference ranges for serial measurements of myocardial performance index (MPI) by conventional and pulsed-wave tissue Doppler in monochorionic diamniotic twins at 17 to 26 weeks of gestation
  204. Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise
  205. Perinatal Outcome of Fetal Umbilical Vein Varix
  206. Brain-injured Survivors of Monochorionic Twin Pregnancies Complicated by Single Intrauterine Death: MR Findings in a Multicenter Study
  207. Cervical-length measurement in mid-gestation to predict spontaneous preterm birth in asymptomatic triplet pregnancy
  208. Management of monochorionic twin pregnancy discordant for body-stalk anomaly
  209. Planned home versus planned hospital births in women at low-risk pregnancy: A systematic review with meta-analysis
  210. Endometriosis, endometrioma, and ART results: Current understanding and recommended practices
  211. Changes in ductus venosus velocity ratios after fetoscopic laser surgery for twin-twin transfusion syndrome
  212. Acetylsalicylic acid in pregnant women with chronic hypertension
  213. 122: Timing of delivery of uncomplicated monochorionic monoamniotic twins
  214. Maternal endothelial function and vascular stiffness after HELLP syndrome: a case-control study
  215. First-trimester screening for pre-eclampsia: time for reflection
  216. Maternal cardiac function after HELLP syndrome: an echocardiography study
  217. Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women
  218. Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study
  219. Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study
  220. A multi-centre, non-inferiority, randomised controlled trial to compare a cervical pessary with a cervical cerclage in the prevention of preterm delivery in women with short cervical length and a history of preterm birth – PC study
  221. Comparative X-ray morphometry of prenatal osteogenesis imperfecta type 2 and thanatophoric dysplasia: a contribution to prenatal differential diagnosis
  222. Longitudinal study of computerized cardiotocography in early fetal growth restriction
  223. How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post‐hoc analysis of TRUFFLE study
  224. Early prediction of twin-to-twin transfusion syndrome: systematic review and meta-analysis
  225. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?
  226. Late appearance of umbilical artery end-diastolic flow in selective intrauterine growth restriction complicating monochorionic diamniotic twin pregnancy
  227. Chromosomal Microarray and Fetal Growth Restriction
  228. Correlation between fetal autopsy and prenatal diagnosis by ultrasound: A systematic review
  229. The search for the ideal microbiota in human reproduction
  230. Re: Validation of a first-trimester screening model for pre-eclampsia in an unselected population. E. Scazzocchio, F. Crovetto, S. Triunfo, E. Gratacós and F. Figueras.Ultrasound Obstet Gynecol2017; 49: 188-193.
  231. Early onset fetal growth restriction
  232. Development of Customized Fetal Growth Charts in Twins
  233. Validation of predictive models for pre-eclampsia
  234. Counselling about the Risk of Preterm Delivery: A Systematic Review
  235. Phase-rectified signal averaging method to predict perinatal outcome in infants with very preterm fetal growth restriction- a secondary analysis of TRUFFLE-trial
  236. Cervical Length at Mid-gestation in Screening for Preterm Birth in Twin Pregnancy
  237. OP17.07: Cervical length measurement at mid‐gestation to predict spontaneous preterm birth in triplet pregnancies
  238. OC02.05: Ductus venosus velocity ratios for prediction of neonatal cardiac dysfunction in early severe fetal growth restriction
  239. OC09.04: Longitudinal reference ranges for serial measurements of myocardial performance index (MPI) by conventional and tissue Doppler in monochorionic diamniotic pregnancies at 17–26 weeks of gestation
  240. P29.02: Umbilical cerebral ratio for detection of poor neonatal acid–base status in small‐for‐gestational age late preterm fetuses
  241. P02.09: Uterine artery Doppler in the management of dichorionic twin pregnancies discordant for intrauterine growth restriction
  242. Outcomes Associated With Isolated Agenesis of the Corpus Callosum: A Meta-analysis
  243. Cervical length at mid-gestation in screening for preterm birth in twin pregnancy
  244. Surgery for endometriosis and outcome of IVF-ET: systematic review and meta-analysis
  245. Intertwin discrepancy in middle cerebral artery peak systolic velocity and third-trimester fetal growth restriction in monochorionic-diamniotic twin pregnancy
  246. Fetal heart monitoring in labour: from pinard to artificial intelligence
  247. Reply
  248. Predicting outcome in 259 fetuses with agenesis of ductus venosus – a multicenter experience and systematic review of the literature
  249. The effect of fetal sex on customized fetal growth charts
  250. Circular RNA and pre-eclampsia: on the long road from the laboratory to the bedside
  251. Elastic properties of ascending aorta in women with previous pregnancy complicated by early- or late-onset pre-eclampsia
  252. 256: Prediction of outcome in 255 fetuses with absent ductus venosus - a multicenter experience and literature review
  253. Customized Fetal Growth Charts for Parents' Characteristics, Race, and Parity by Quantile Regression Analysis
  254. Amniocentesis for fetal karyotyping: the end of an era?
  255. Placental morphology in pregnancies associated with pregravid obesity
  256. 2 Year Neurodevelopmental and Intermediate Perinatal Outcomes in Infants With Very Preterm Fetal Growth Restriction (TRUFFLE)
  257. Outcome of monochorionic diamniotic twin pregnancies followed at a single center
  258. Microwave Ablation in Complicated Monochorionic Twin Pregnancies
  259. Neonatal morbidity after cesarean section before labor at 34+0to 38+6weeks: a cohort study
  260. Polyhydramnios in sac of parasitic twin: atypical manifestation of twin reversed arterial perfusion sequence
  261. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  262. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus
  263. Reply: fruit and fetal brain MRI - the cherry-picking approach to systematic reviews
  264. Quality of first trimester risk prediction models for pre-eclampsia: a systematic review
  265. Re: Transverse vaginal septae: management and long-term outcomes
  266. Reply: Apples, oranges and fetal brain MRI
  267. The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature
  268. Re: Iatrogenic perforation of intertwin membrane after laser surgery for twin‐to‐twin transfusion syndrome. S. H. P. Peeters, T. T. Stolk, F. Slaghekke, J. M. Middeldorp, F. J. Klumper, E. Lopriore and D. Oepkes. Ultrasound Obstet Gynecol 2014; 44: 550...
  269. Fetal cardiac parameters for prediction of twin‐to‐twin transfusion syndrome
  270. Pregnancy outcomes of induced labor in women with previous cesarean section: a systematic review and meta-analysis
  271. OC23.05: Inter-twin discordance in mean cerebral artery peak systolic velocity and pregnancy outcome in monochorionic diamniotic twin pregnancies
  272. OP11.04: Fetal cardiac parameters for the prediction of twin-twin transfusion syndrome
  273. OP11.10: Spontaneous preterm birth in triplet pregnancies is independent from cervical length measurement at mid-gestation
  274. OP30.04: Cervical length measurement in twin pregnancies at 18-22 weeks: not the best test for all preterm births
  275. P02.15: Body stalk anomaly in monoamniotic twins at 9 weeks
  276. P14.31: First trimester risk prediction models for pre-eclampsia based on uterine artery Doppler: a systematic review of methodology
  277. P19.12: The natural history of monoamniotic twin pregnancies
  278. P19.18: Polyhydramnios in the sac of the parasitic twin: atypical manifestation of twin-reversed arterial perfusion sequence
  279. Additional value of fetal magnetic resonance imaging in the prenatal diagnosis of central nervous system anomalies: a systematic review of the literature
  280. Perinatal Outcomes of Twin Anemia–Polycythemia Sequence: A Systematic Review
  281. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  282. Concordant body stalk anomaly in a monoamniotic twin pregnancy at 9 weeks
  283. Re: Uterine artery Doppler and sFlt‐1/PlGF ratio: prognostic value in early‐onset pre‐eclampsia. P. I. Gómez‐Arriaga, I. Herraiz, E. A. López‐Jiménez, D. Escribano, B. Denk and A. Galindo. Ultrasound Obstet Gynecol 2014; 43: 525–532
  284. The prognostic role of various indices and ratios of Doppler velocimetry in patients with pre-eclampsia
  285. Fetal abdominal wall defects
  286. Fetal Surgery
  287. Rapid cervical phIGFBP-1 test in asymptomatic twin pregnancies: role in mid-pregnancy prediction of spontaneous preterm delivery
  288. Fetoscopic cord transection for treatment of monoamniotic twin reversed arterial perfusion sequence
  289. 203: The effects of vanishing twin on perinatal outcomes of the co-twin: a systematic review with meta-analysis
  290. Fetal weight estimation in gestational diabetic pregnancies: comparison between conventional and three-dimensional fractional thigh volume methods using gestation-adjusted projection
  291. Accuracy of Ultrasonography at 11–14 Weeks of Gestation for Detection of Fetal Structural Anomalies
  292. Comment on “Long‐term outcomes of children with umbilical vein varix diagnosed prenatally”
  293. Prevention, Management, and Outcomes of Macrosomia
  294. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  295. Pregnancy week at delivery and the risk of shoulder dystocia: a population study of 2 014 956 deliveries
  296. Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R
  297. Perinatal outcomes of isolated oligohydramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis
  298. Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  299. Cervical cerclage in twin pregnancies
  300. The use of radiofrequency in the treatment of twin reversed arterial perfusion sequence: a case series and review of the literature
  301. Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature
  302. Re: Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature. A. C. Rossi and F. Prefumo. Ultrasound Obstet Gynecol 2013; 41: 131–135
  303. ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetrics
  304. Effects of antenatal recognition and follow‐up on perinatal outcomes in small‐for‐gestational age infants delivered after 36 weeks
  305. I299 EVIDENCE‐BASED APPLICATION OF 3D/4D ULTRASOUND IN FETAL MEDICINE: OVERVIEW
  306. Re: Effect of letrozole on uterine artery Doppler flow indices prior to first-trimester termination of pregnancy: a randomized controlled trial. V. C. Y. Lee, T. W. Y. Yeung, O. S. Tang, E. H. Y. Ng, W. S. B. Yeung and P. C. Ho. Ultrasound Obstet Gynecol
  307. OP06.07: Preliminary experience with microwave ablation for selective feticide in monochorionic twin pregnancies
  308. P08.15: The role of uterine artery pulsatility index for prediction of outcome in pregnancies complicated by pre-eclampsia
  309. PP110. The role of doppler to predict adverse pregnancy outcome in patients with pre-eclampsia
  310. Conservative management in a case of iatrogenic twin anemia–polycythemia sequence
  311. Effects of Epidural Analgesia on Uterine Artery Doppler in Labor
  312. OC09.02: Complications and outcome of invasive prenatal diagnosis in twin pregnancies
  313. The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women
  314. Successful management of a triplet heterotopic caesarean scar pregnancy after in vitro fertilization-embryo transfer
  315. Nuchal translucency thickness and crown rump length discordance for the prediction of outcome in monochorionic diamniotic pregnancies
  316. Practice guidelines for performance of the routine mid‐trimester fetal ultrasound scan
  317. Effects of epidural analgesia on uterine artery Doppler in labour
  318. P19.05: Obstetric and perinatal outcomes in triplet pregnancies in relation to chorionicity
  319. OC03.05: Effects of antenatal identification on perinatal outcomes in small for gestational age infants delivered after 34 weeks' gestation
  320. P06.09: Fetoscopic laser treatment for twin–twin transfusion syndrome: preliminary results from a new Italian center
  321. OP06.01: A systematic review of first trimester nuchal translucency for the prediction of twin‐to‐twin transfusion syndrome
  322. A randomized controlled trial of 24‐hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score ≤ 4
  323. Single umbilical artery and congenital heart disease in selected and unselected populations
  324. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin‐to‐twin transfusion syndrome
  325. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  326. OP11.11: Effects of epidural analgesia on uterine artery Doppler in labour
  327. P06.08: Successful management of a heterotopic twin pregnancy on Cesarean scar combined with a viable intrauterine pregnancy
  328. P26.06: Increased concentrations of antiangiogenic factors in mirror syndrome complicating TTTS
  329. P05.16: Interobserver repeatability of transabdominal 3D ultrasound of the fetal brain
  330. OC26.02: Fetal weight estimation in pregnancy complicated by obesity: comparison between conventional and a new 3D ultrasound method
  331. OP14.03: Longitudinal study of maternal insulin-like growth factor-I and uterine artery Doppler
  332. OC20.01: Cardiovascular function in women with a previous pregnancy complicated by early onset pre-eclampsia
  333. OP18.03: Nuchal translucency thickness discordance for prediction of severe twin-twin transfusion syndrome
  334. OP34.05: Outcome of monochorionic diamniotic pregnancies followed at a single Twin Clinic
  335. Interobserver Reproducibility of Transabdominal 3-Dimensional Sonography of the Fetal Brain
  336. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  337. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  338. Adnexal torsion in late pregnancy
  339. Stepwise sequential screening for trisomy 21 in assisted reproduction pregnancies
  340. Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre-eclampsia
  341. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  342. Prenatal imaging of ductus venosus agenesis using 4D ultrasound with a matrix array transducer
  343. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  344. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  345. Acute Premature Constriction of the Ductus Arteriosus after Maternal Self-Medication with Nimesulide
  346. Association between birth weight and first-trimester free β–human chorionic gonadotropin and pregnancy-associated plasma protein A
  347. Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction
  348. Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker
  349. P41.03: Uterine artery Doppler at 10–14 weeks and maternal serum concentrations of asymmetric dimethylarginine
  350. OP01.10: Third trimester uterine artery Doppler and adverse obstetric outcome
  351. OP13.08: Corpus callosum abnormalities: 2D, 3D ultrasound and MRI
  352. P27.14: Fetal cystic hygroma and mid‐trimester maternal serum screening
  353. OP14.01: Uterine artery Doppler at 10–14 weeks and the interaction between decidual NK cells and extravillous trophoblast: an immunohistochemical study
  354. OP01.03: Maternal cardiovascular function and ambulatory blood pressure monitoring in pregnancies complicated by fetal growth restriction
  355. OC138: The combination of short cervical length and phIGFBP‐1 in the prediction of preterm delivery
  356. P32.17: Real‐time 3D ultrasound using a matrix array transducer: a case of agenesis of the ductus venosus
  357. OP19.05: A comparison of cervical length measurement and phIGFBP‐1 in the prediction of preterm delivery
  358. Cystic hygroma and mid-trimester maternal serum screening
  359. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  360. Matrix Array Transducers in Fetal Heart Imaging
  361. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  362. Apparently isolated borderline ventriculomegaly and lissencephaly
  363. Outcome of prenatally diagnosed agenesis of the corpus callosum
  364. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  365. Analysis of Natural Killer Cells Isolated from Human Decidua: Evidence that 2B4 (CD244) Functions as an Inhibitory Receptor and Blocks NK Cell Function
  366. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  367. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function
  368. Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein
  369. Maternal cardiac function in early pregnancies with high uterine artery resistance
  370. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  371. Correlation between first-trimester uterine artery Doppler indices and maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A
  372. Correlation between first trimester fetal bone length and maternal serum pregnancy-associated plasma protein-A (PAPP-A)
  373. P04.18: Acute premature constriction of the ductus arteriosus after maternal self‐medication with nimesulide
  374. P07.01: First‐trimester uterine artery Doppler in women with previous pre‐eclampsia
  375. OP07.01: First‐trimester uterine artery Doppler and spontaneous preterm delivery
  376. OP07.03: First‐trimester uterine artery Doppler and small‐for‐gestational‐age infants
  377. OP18.02: Contrast‐enhanced ultrasound (CEU) before and after uterine artery embolisation (UAE) for fibroid treatment
  378. P14.06: Difficult differential diagnosis of an occipital mass
  379. P07.02: First‐trimester uterine artery Doppler and pre‐eclampsia
  380. OC117: Transvaginal ultrasound (TVUS) and sonohysterography (SHG) in the preoperative staging of submucous fibroids
  381. OP13.03: Assessment of palpable nodules of the abdominal wall with postpartum onset
  382. P14.03: Prenatal diagnosis of septal agenesis with normal pituitary function
  383. P02.72: Prenatal diagnosis of Meckel–Gruber syndrome in a pregnancy deriving from ICSI
  384. OC75: Differential diagnosis of uterine myomas and adenomyosis by color Doppler (CD) and contrast‐enhanced ultrasound (CEU)
  385. Assessment of the intraobserver variability in the measurement of fetal cardiothoracic ratio using ellipse and diameter methods
  386. Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI
  387. Influence of parity on first trimester endovascular trophoblast invasion
  388. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  389. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  390. Clinical implications of an anatomical variant of the ductus venosus
  391. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  392. Prenatal diagnosis of septal agenesis with normal pituitary function
  393. Prenatal diagnosis of a nasal glioma in the mid trimester
  394. Association of first trimester uterine artery Doppler, maternal diastolic cardiac function and ischaemia modified albumin
  395. Trisomy18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result
  396. The association between p53 expression, stage and histological features in endometrial cancer
  397. P15.12: Association of first trimester uterine artery Doppler indices with maternal diastolic cardiac function
  398. OC32.02: First‐trimester uterine artery Doppler and ischaemia modified albumin in women who subsequently develop severe pre‐eclampsia
  399. A newly described thoracic vascular malformation in fetuses with Down syndrome
  400. Acute Presentation of Fetal Hypertrophic Cardiomyopathy in a Type 1 Diabetic Pregnancy
  401. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  402. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  403. First-trimester fetal nuchal translucency and inherited metabolic disorders
  404. Prenatal sonographic findings in a case of Varadi–Papp syndrome
  405. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  406. P10.08: First trimester nasal bones and trisomy 21 in a low‐risk population
  407. P10.09: First trimester ductus venosus, nasal bones and trisomy 21 in a high‐risk population
  408. OC007: Long axis ventricular function in normal fetuses
  409. OC154: Pregnancy outcome of antenatally diagnosed agenesis of the corpus callosum
  410. OC027: Single umbilical artery and congenital heart disease in high‐ and low‐risk populations
  411. P14.42: Sonographic resolution of severe uretero‐pelvic junction obstruction in utero associated with complete absence of neonatal kidney function
  412. P11.12: Fetal Gollop‐Wolfgang complex associated with de novo chromosomal rearrangements typical of split‐hand/split‐foot anomaly
  413. OC046: The investigation of fetal arrhythmias by simultaneous pulsed wave Doppler recording of pulmonary artery and vein
  414. P08.01: Relationship of uterine artery Doppler and trophoblast invasion in the first trimester of pregnancy
  415. P01.03: Assessment of the intra‐observer variability in the measurement of fetal cardio‐thoracic ratio using ellipse and diameter methods
  416. OC065: Uterine artery resistance at 10–14 weeks of gestation is correlated with trophoblast apoptosis
  417. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  418. Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier number 7)
  419. Vasa Previa: The Impact of Prenatal Diagnosis on Outcomes
  420. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  421. Primary and secondary malignancies of the penis: ultrasound features
  422. Maternal ethnic origin and fetal nasal bones at 11–14 weeks of gestation
  423. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae
  424. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  425. Decreased endovascular trophoblast invasion in first-trimester pregnancies with high-resistance uterine artery doppler indices
  426. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  427. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  428. Ultrasound-Guided Interstitial Laser Therapy for the Treatment of Placental Chorioangioma
  429. First‐trimester uterine artery blood flow and birth weight
  430. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  431. Cardiac surgery during pregnancy: pulsatile or nonpulsatile perfusion?
  432. Early resolution of increased nuchal translucency in a fetus with trisomy 18
  433. Effect of fetal gender on first‐trimester ductus venosus blood flow
  434. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  435. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinico-pathologic entity
  436. Association Between Increased Nuchal Translucency and Second Trimester Cardiac Echogenic Foci
  437. Early vaginal bleeding and first‐trimester markers for Down syndrome
  438. The role of oxytocin in parturition
  439. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  440. Nuchal Translucency and Early Diagnosis of Congenital Anomalies
  441. Analysis of p53 and c-erbB-2 Expression in Ovarian Endometrioid Carcinomas Arising in Endometriosis
  442. OC202: Longitudinal variation of uterine artery waveforms and birthweight
  443. P300: Natural and unnatural history of first trimester cardiac diverticula
  444. P172: Ultrasound prenatal diagnosis of a lateral facial cleft (Tessier n. 7)
  445. P022: The correlation between early pregnancy ultrasound measurements and fetal nuchal translucency
  446. P020: Second trimester uterine artery Dopplers and preterm delivery
  447. P018: Maternal haematological parameters and uterine artery bloodflow
  448. OC020: Is the discriminatory zone an outdated concept?
  449. The sonographic evaluation of tubal patency with stimulated acoustic emission imaging
  450. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  451. Reference values for ductus venosus Doppler flow measurements at 10–14 weeks of gestation
  452. Trisomy 18 in a fetus with normal NT and abnormal maternal serum biochemistry
  453. Reference values for fetal limb biometry at 10–14 weeks of gestation
  454. Epithelial Abnormalities in Cystic Ovarian Endometriosis
  455. Comparison of First Trimester, Second Trimester and Integrated Downs Syndrome Screening Results in Unaffected Pregnancies
  456. A defective expression of ICAM-1 (CD54) on secretory endometrial cells is associated with endometriosis
  457. Isolated echogenic foci in the fetal heart: do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency?
  458. Reproducibility of ductus venosus Doppler flow measurements at 11–14 weeks of gestation
  459. Prenatal diagnosis of mosaic trisomy 8 in a fetus with normal nuchal translucency thickness and reversed end‐diastolic ductus venosus flow
  460. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  461. The prenatal diagnosis of Binder syndrome before 24 weeks of gestation: case report
  462. Extent of correlation between first and second trimester markers for Down's syndrome screening
  463. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation
  464. Reply